Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,698.40
(
-0.41%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
111.71
(
4.81%
)
Bitcoin
70,043.07
(
-1.68%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 164820

Thursday, 08/01/2013 6:17:14 PM

Thursday, August 01, 2013 6:17:14 PM

Post# of 257257

Teva's CEO said they are prepared with aggressive launch of 3x week Copaxone if approved by FDA in 2014.

The comment about “an aggressive launch” was obligatory and essentially vacuous, but the CEO also said Teva will continue to detail regular Copaxone even if they get FDA approval for the thrice-weekly product. This is new information.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now